3 278

Cited 0 times in

Favorable neointimal coverage in everolimus-eluting stent at 9 months after stent implantation: comparison with sirolimus-eluting stent using optical coherence tomography.

DC FieldValueLanguage
dc.contributor.author장양수-
dc.contributor.author최동훈-
dc.contributor.author홍명기-
dc.contributor.author고영국-
dc.contributor.author김병극-
dc.contributor.author김중선-
dc.contributor.author김태훈-
dc.date.accessioned2014-12-19T16:55:38Z-
dc.date.available2014-12-19T16:55:38Z-
dc.date.issued2012-
dc.identifier.issn1569-5794-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/90453-
dc.description.abstractRecent studies reported favorable angiographic and clinical outcomes after everolimus-eluting stent (EES) implantation. However, there were no studies to assess vascular responses after EES implantation using optical coherence tomography (OCT). Therefore, the OCT findings in EES were investigated and compared with those in sirolimus-eluting stent (SES). Follow-up OCT studies were performed in 110 lesions (40 EES and 70 SES) of 104 patients at 9 months after stent implantation. The strut apposition, neointimal hyperplasia (NIH) thickness and stent coverage on each stent struts were evaluated. The mean NIH thickness was significantly greater in EES-treated lesions than in SES-treated lesions (115 ± 52 μm vs. 89 ± 58 μm, P = 0.001, respectively). The percentage of uncovered strut was significantly smaller in EES-treated lesions than in SES-treated lesions (4.4 ± 4.7% vs. 10.5 ± 12.7%, P = 0.016, respectively). There was no significant difference in the percentage of malapposed strut between the two groups (0.4 ± 0.8% in EES vs. 1.7 ± 4.5% in SES, P = 0.344). The incidence of intracoronary thrombus was significantly lower in EES-treated lesions than in SES-treated lesions (5.0% vs. 34.3%, P < 0.001, respectively). EES showed a significantly lower incidence of uncovered stent struts and intracoronary thrombus than SES in 9-month follow-up OCT examination. Compared to SES, EES might have more favorable vascular responses after stent implantation.-
dc.description.statementOfResponsibilityopen-
dc.relation.isPartOfINTERNATIONAL JOURNAL OF CARDIOVASCULAR IMAGING-
dc.rightsCC BY-NC-ND 2.0 KR-
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/2.0/kr/-
dc.subject.MESHAged-
dc.subject.MESHAngioplasty, Balloon, Coronary/adverse effects-
dc.subject.MESHAngioplasty, Balloon, Coronary/instrumentation*-
dc.subject.MESHCardiovascular Agents/administration & dosage*-
dc.subject.MESHChi-Square Distribution-
dc.subject.MESHCoronary Angiography-
dc.subject.MESHCoronary Artery Disease/diagnostic imaging-
dc.subject.MESHCoronary Artery Disease/therapy*-
dc.subject.MESHCoronary Restenosis/etiology-
dc.subject.MESHCoronary Restenosis/pathology-
dc.subject.MESHCoronary Restenosis/prevention & control*-
dc.subject.MESHCoronary Thrombosis/etiology-
dc.subject.MESHCoronary Thrombosis/prevention & control-
dc.subject.MESHCoronary Vessels/drug effects*-
dc.subject.MESHCoronary Vessels/pathology-
dc.subject.MESHDrug-Eluting Stents*-
dc.subject.MESHEverolimus-
dc.subject.MESHFemale-
dc.subject.MESHHumans-
dc.subject.MESHHyperplasia-
dc.subject.MESHMale-
dc.subject.MESHMiddle Aged-
dc.subject.MESHNeointima-
dc.subject.MESHPredictive Value of Tests-
dc.subject.MESHRegistries-
dc.subject.MESHRepublic of Korea-
dc.subject.MESHRetrospective Studies-
dc.subject.MESHSirolimus/administration & dosage-
dc.subject.MESHSirolimus/analogs & derivatives*-
dc.subject.MESHTime Factors-
dc.subject.MESHTomography, Optical Coherence*-
dc.subject.MESHTreatment Outcome-
dc.titleFavorable neointimal coverage in everolimus-eluting stent at 9 months after stent implantation: comparison with sirolimus-eluting stent using optical coherence tomography.-
dc.typeArticle-
dc.contributor.collegeCollege of Medicine (의과대학)-
dc.contributor.departmentDept. of Internal Medicine (내과학)-
dc.contributor.googleauthorHyun Hee Choi-
dc.contributor.googleauthorJung-Sun Kim-
dc.contributor.googleauthorDuck Hyoung Yoon-
dc.contributor.googleauthorKyung-Soon Hong-
dc.contributor.googleauthorTae Hoon Kim-
dc.contributor.googleauthorByeong Keuk Kim-
dc.contributor.googleauthorYoung-Guk Ko-
dc.contributor.googleauthorDonghoon Choi-
dc.contributor.googleauthorYangsoo Jang-
dc.contributor.googleauthorMyeong-Ki Hong-
dc.identifier.doi21442265-
dc.admin.authorfalse-
dc.admin.mappingfalse-
dc.contributor.localIdA03448-
dc.contributor.localIdA04053-
dc.contributor.localIdA04391-
dc.contributor.localIdA00127-
dc.contributor.localIdA00493-
dc.contributor.localIdA00961-
dc.contributor.localIdA01085-
dc.relation.journalcodeJ01094-
dc.identifier.eissn1875-8312-
dc.identifier.pmid21442265-
dc.identifier.urlhttp://link.springer.com/article/10.1007%2Fs10554-011-9849-7-
dc.subject.keywordOptical coherence tomography-
dc.subject.keywordStent-
dc.contributor.alternativeNameJang, Yang Soo-
dc.contributor.alternativeNameChoi, Dong Hoon-
dc.contributor.alternativeNameHong, Myeong Ki-
dc.contributor.alternativeNameKo, Young Guk-
dc.contributor.alternativeNameKim, Byeong Keuk-
dc.contributor.alternativeNameKim, Jung Sun-
dc.contributor.alternativeNameKim, Tae Hoon-
dc.contributor.affiliatedAuthorJang, Yang Soo-
dc.contributor.affiliatedAuthorChoi, Dong Hoon-
dc.contributor.affiliatedAuthorHong, Myeong Ki-
dc.contributor.affiliatedAuthorKo, Young Guk-
dc.contributor.affiliatedAuthorKim, Byeong Keuk-
dc.contributor.affiliatedAuthorKim, Jung Sun-
dc.contributor.affiliatedAuthorKim, Tae-Hoon-
dc.citation.volume28-
dc.citation.number3-
dc.citation.startPage491-
dc.citation.endPage497-
dc.identifier.bibliographicCitationINTERNATIONAL JOURNAL OF CARDIOVASCULAR IMAGING, Vol.28(3) : 491-497, 2012-
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Internal Medicine (내과학교실) > 1. Journal Papers

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.